Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | HBB | P68871 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9548329 | 0.78 | SMN1; SMN2 (0.44) | HIF1AALDH1A1 | |
| SCHEMBL28272721 | 0.75 | TSHR (0.35) | TSHRLMNAMEN1KMT2ABLM | |
| SCHEMBL2124564 | 0.73 | ALDH1A1 (0.36) | TSHRLMNAMEN1KMT2ABLM | |
| SCHEMBL19283720 | 0.70 | TSHR (0.31) | TSHRFFAR3 | |
| SCHEMBL8849281 | 0.69 | CYP2D6 (0.34) | TSHRHIF1AALDH1A1 | |
| SCHEMBL30855502 | 0.67 | ALDH1A1 (0.31) | MEN1KMT2AALDH1A1CYP1A2THRB | |
| SCHEMBL28271770 | 0.67 | ALDH1A1 (0.32) | TSHRLMNAMEN1KMT2ABLM | |
| SCHEMBL28271161 | 0.67 | ALDH1A1 (0.32) | TSHRLMNAMEN1KMT2ABLM | |
| SCHEMBL9695614 | 0.67 | ALDH1A1 (0.35) | TSHRLMNAMEN1KMT2ABLM | |
| SCHEMBL11219296 | 0.65 | ALDH1A1 (0.33) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115821264-A | Etching solution composition | TCL华星光电技术有限公司 | 2023-03-21 | — | — | CN | claimed |
| CN-115763494-A | Display panel, manufacturing method thereof and etching solution composition | TCL华星光电技术有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115368899-A | Etching solution, oxide semiconductor device and etching method | TCL华星光电技术有限公司 | 2022-11-22 | — | — | CN | claimed |
| CN-115261858-A | Etching solution composition and application thereof | 广州华星光电半导体显示技术有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-114540817-A | Etching solution composition, display panel and preparation method thereof | TCL华星光电技术有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-114182259-A | Etching solution | TCL华星光电技术有限公司 | 2022-03-15 | — | — | CN | claimed |
| CN-115763494-B | Display panel, manufacturing method thereof and etching liquid composition | TCL华星光电技术有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-116180082-A | Etching liquid composition | TCL华星光电技术有限公司 | 2023-05-30 | — | — | CN | disclosed |
| CN-115821264-A | Etching solution composition | TCL华星光电技术有限公司 | 2023-03-21 | — | — | CN | disclosed |
| CN-115763494-A | Display panel, manufacturing method thereof and etching solution composition | TCL华星光电技术有限公司 | 2023-03-07 | — | — | CN | disclosed |
| CN-115368899-A | Etching solution, oxide semiconductor device and etching method | TCL华星光电技术有限公司 | 2022-11-22 | — | — | CN | disclosed |
| CN-115261858-A | Etching solution composition and application thereof | 广州华星光电半导体显示技术有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-114540817-A | Etching solution composition, display panel and preparation method thereof | TCL华星光电技术有限公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-114182259-A | Etching solution | TCL华星光电技术有限公司 | 2022-03-15 | — | — | CN | disclosed |
| US-20090246169-A1 | INDOLOPYRIDINES AS EG5 KINESIN MODULATORS | NYCOMED GMBH (DE) | 2009-10-01 | — | — | US | disclosed |
| EP-1994033-A1 | INDOLOPYRIDINES AS EG5 KINESIN MODULATORS | 4SC AG (DE) | 2008-11-26 | — | — | EP | disclosed |
| WO-2007096395-A1 | INDOLOPYRIDINES AS EG5 KINESIN MODULATORS | 4SC AG (DE) | 2007-08-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090246169-A1 | INDOLOPYRIDINES AS EG5 KINESIN MODULATORS | KIF5A, KIF5C, KIF5B | TSHR 3884/4885LMNA 3053/4885MEN1 4082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.